These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10862433)

  • 1. Are cirrhosis and its complications inevitable in hepatitis C virus infection?
    Delahooke TE; Hayes PC
    Scott Med J; 2000 Apr; 45(2):35-7. PubMed ID: 10862433
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors associated with the progression of hepatic fibrosis in end-stage kidney disease patients with hepatitis C virus infection.
    Becker VR; Badiani RG; Lemos LB; Perez RM; Medina-Pestana JO; Lanzoni VP; Ferreira AP; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1395-9. PubMed ID: 19525852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fibrosis progression in hepatitis C].
    Tateishi R; Yoshida H; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):585-9. PubMed ID: 15359865
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural history and predictors of disease severity in chronic hepatitis C.
    Massard J; Ratziu V; Thabut D; Moussalli J; Lebray P; Benhamou Y; Poynard T
    J Hepatol; 2006; 44(1 Suppl):S19-24. PubMed ID: 16356583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild alcohol consumption is not associated with increased fibrosis in patients with chronic hepatitis C.
    Cheung O; Sterling RK; Salvatori J; Williams K; Hubbard S; Luketic VA; Stravitz TR; Sanyal AJ; Contos MJ; Mills S; Shiffman ML
    J Clin Gastroenterol; 2011 Jan; 45(1):76-82. PubMed ID: 20818236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression to cirrhosis in Latinos with chronic hepatitis C: differences in Puerto Ricans with and without human immunodeficiency virus coinfection and along gender.
    Rodríguez-Torres M; Ríos-Bedoya CF; Rodríguez-Orengo J; Fernández-Carbia A; Marxuach-Cuétara AM; López-Torres A; Salgado-Mercado R; Bräu N
    J Clin Gastroenterol; 2006 Apr; 40(4):358-66. PubMed ID: 16633110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus.
    Puoti M; Bonacini M; Spinetti A; Putzolu V; Govindarajan S; Zaltron S; Favret M; Callea F; Gargiulo F; Donato F; Carosi G;
    J Infect Dis; 2001 Jan; 183(1):134-7. PubMed ID: 11087200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heavy drinking greatly increases the risk of cirrhosis in patients with HCV hepatitis.
    Day CP
    Gut; 2001 Dec; 49(6):750-1. PubMed ID: 11709504
    [No Abstract]   [Full Text] [Related]  

  • 10. [What does chronic hepatitis C steatosis mean?].
    Asselah T; Ripault MP; Marcellin P
    Gastroenterol Clin Biol; 2003 Dec; 27(12):1073-5. PubMed ID: 14770105
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of genetic polymorphisms in the progression of liver fibrosis in chronic hepatitis C virus infection.
    Papatheodoridis GV; Paraskevis D
    Liver Int; 2008 Jul; 28(6):764-6. PubMed ID: 18647140
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of common risk factors of fibrosis progression in chronic hepatitis C.
    Rüeger S; Bochud PY; Dufour JF; Müllhaupt B; Semela D; Heim MH; Moradpour D; Cerny A; Malinverni R; Booth DR; Suppiah V; George J; Argiro L; Halfon P; Bourlière M; Talal AH; Jacobson IM; Patin E; Nalpas B; Poynard T; Pol S; Abel L; Kutalik Z; Negro F
    Gut; 2015 Oct; 64(10):1605-15. PubMed ID: 25214320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cytokine levels as putative prognostic markers in the progression of chronic HCV hepatitis to cirrhosis.
    Costantini S; Capone F; Guerriero E; Maio P; Colonna G; Castello G
    Eur Cytokine Netw; 2010 Dec; 21(4):251-6. PubMed ID: 21081303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating progression to cirrhosis in chronic hepatitis C virus infection.
    Freeman AJ; Dore GJ; Law MG; Thorpe M; Von Overbeck J; Lloyd AR; Marinos G; Kaldor JM
    Hepatology; 2001 Oct; 34(4 Pt 1):809-16. PubMed ID: 11584380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C.
    Luo JC; Hwang SJ; Chang FY; Chu CW; Lai CR; Wang YJ; Lee PC; Tsay SH; Lee SD
    Hepatogastroenterology; 2002; 49(44):478-81. PubMed ID: 11995477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of chronic hepatitis C.
    Pagliaro L; Peri V; Linea C; Cammà C; Giunta M; Magrin S
    Ital J Gastroenterol Hepatol; 1999; 31(1):28-44. PubMed ID: 10091101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progression and risk factors for hepatocarcinogenesis in hepatitis C-related cirrhosis--viral factors, host factors, and others].
    Hoshida Y; Kato N; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):596-9. PubMed ID: 15359867
    [No Abstract]   [Full Text] [Related]  

  • 18. Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection.
    Thursz M
    Gut; 2007 May; 56(5):613-4. PubMed ID: 17440181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical course of infection with hepatitis C.
    Vento S; Nobili V; Cainelli F
    BMJ; 2006 Feb; 332(7538):374-5. PubMed ID: 16484241
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: a longitudinal long-term cohort study.
    Kielland KB; Delaveris GJ; Rogde S; Eide TJ; Amundsen EJ; Dalgard O
    J Hepatol; 2014 Feb; 60(2):260-6. PubMed ID: 24096048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.